Skip to content
healthcare.dev

COSENTYX

NDC 0078-1168, secukinumab, injection, solution, concentrate, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-1168
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761349
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1168 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SECUKINUMAB25 mg/mL

Pharmacologic classes

Interleukin-17A Antagonist [EPC]; Interleukin-17A Antagonists [MoA]

Package NDCNDC-11Package
0078-1168-61000781168615 mL in 1 VIAL, GLASS (0078-1168-61)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/77c4b13e-7df3-42d4-81db-3d0cddb7f67a
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0078-1168

Use it

Look up 0078-1168 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1168 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-1168. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.